Chini E N, Dousa T P
Department of Physiology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
Am J Physiol. 1996 Feb;270(2 Pt 1):C530-7. doi: 10.1152/ajpcell.1996.270.2.C530.
Cyclic ADP-ribose (cADPR) is a potent mediator of Ca2+ mobilization from intracellular stores in sea urchin eggs that ultimately activates the ryanodine channel. We now report that certain long-chain acyl-CoA derivative metabolites (14-18 carbons in length), such as palmitoyl-CoA, greatly potentiate the effect of cADPR on Ca2+ release. Furthermore, in higher concentrations, palmitoyl-CoA and other closely related long-chain acyl-CoA derivatives trigger Ca2+ release apparently through the ryanodine channel in sea urchin egg homogenates. Palmitoyl-CoA-induced Ca2+ release was suppressed by ruthenium red, spermine, and the calmodulin antagonist N-(6-aminohexyl)-1-naphthalenesulfonamide, which all prevent activation of the ryanodine channel, but not by heparin or thionicotinamide-NADP. In addition, cADPR was able to desensitize the sea urchin egg homogenates to the subsequent Ca2+ release induced by palmitoyl-CoA and vice versa. In contrast, neither inositol 1,4,5-trisphosphate (IP3) nor the newly identified Ca2+ release agonist nicotinate adenine dinucleotide phosphate was able to desensitize the homogenate to palmitoyl-CoA, indicating that palmitoyl-CoA probably acts selectively by activating the ryanodine channel, but, unlike cADPR, palmitoyl-CoA might act directly on this channel. Finally, we found that palmitoyl-CoA was able to counteract the inhibitory effect of Mg2+ and spermine, which, in physiological concentrations, suppress specifically the cADPR-induced Ca2+ release. We propose that palmitoyl-CoA, present in micromolar concentrations, may trigger Ca2+ release through the ryanodine channel and, in lower concentrations, may increase the sensitivity of the Ca2+ release system to cADPR. Thus palmitoyl-CoA may serve as a regulatory link between the intermediary metabolism and the cADPR-induced Ca2+ release signaling pathway.
环磷酸腺苷核糖(cADPR)是海胆卵中从细胞内储存库动员钙离子的一种有效介质,最终激活兰尼碱受体通道。我们现在报告,某些长链酰基辅酶A衍生物代谢物(长度为14 - 18个碳),如棕榈酰辅酶A,能极大地增强cADPR对钙离子释放的作用。此外,在较高浓度下,棕榈酰辅酶A和其他密切相关的长链酰基辅酶A衍生物显然通过海胆卵匀浆中的兰尼碱受体通道触发钙离子释放。棕榈酰辅酶A诱导的钙离子释放受到钌红、精胺和钙调蛋白拮抗剂N -(6 - 氨基己基)- 1 - 萘磺酰胺的抑制,这些物质都能阻止兰尼碱受体通道的激活,但不受肝素或硫代烟酰胺 - NADP的抑制。此外,cADPR能够使海胆卵匀浆对随后由棕榈酰辅酶A诱导的钙离子释放产生脱敏作用,反之亦然。相比之下,肌醇1,4,5 - 三磷酸(IP3)和新发现的钙离子释放激动剂烟酰胺腺嘌呤二核苷酸磷酸都不能使匀浆对棕榈酰辅酶A产生脱敏作用,这表明棕榈酰辅酶A可能通过激活兰尼碱受体通道选择性地发挥作用,但与cADPR不同,棕榈酰辅酶A可能直接作用于该通道。最后,我们发现棕榈酰辅酶A能够抵消镁离子和精胺的抑制作用,在生理浓度下,镁离子和精胺会特异性地抑制cADPR诱导的钙离子释放。我们提出,微摩尔浓度的棕榈酰辅酶A可能通过兰尼碱受体通道触发钙离子释放,而在较低浓度下,可能会增加钙离子释放系统对cADPR的敏感性。因此,棕榈酰辅酶A可能作为中间代谢与cADPR诱导的钙离子释放信号通路之间的调节纽带。